Phase I Exploratory Study of IV Formulation of Panobinostat in Combination with Bortezomib in Relapsed/Refractory Multiple Myeloma Patients: Effect On Serum PTH and Gene Expression Profiling (GEP) Studies

Maurizio Zangari, Fenghuang Zhan, Giampaolo Talamo et al.|Blood|2012

Cited by 2